These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 697173)

  • 21. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent kinetics of theophylline in adults with pulmonary diseases.
    Massey KL; Gotz VP; Russell WL
    Ther Drug Monit; 1984; 6(3):284-9. PubMed ID: 6506135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of theophylline in children with asthma.
    Ellis EF; Koysooko R; Levy G
    Pediatrics; 1976 Oct; 58(4):542-7. PubMed ID: 972795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline kinetics in acute pulmonary edema.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    Clin Pharmacol Ther; 1977 Mar; 21(3):310-6. PubMed ID: 837650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T; Józefczak E; Raczka A
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of passive smoking on theophylline clearance.
    Matsunga SK; Plezia PM; Karol MD; Katz MD; Camilli AE; Benowitz NL
    Clin Pharmacol Ther; 1989 Oct; 46(4):399-407. PubMed ID: 2791443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theophylline clearance in obese patients in relation to smoking and congestive heart failure.
    Slaughter RL; Lanc RA
    Drug Intell Clin Pharm; 1983 Apr; 17(4):274-6. PubMed ID: 6839957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette abstinence, nicotine gum, and theophylline disposition.
    Lee BL; Benowitz NL; Jacob P
    Ann Intern Med; 1987 Apr; 106(4):553-5. PubMed ID: 3826954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
    Romero R; Kadar N; Gonzales Govea F; Hobbins JC
    Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

  • 31. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction.
    Yano I; Tanigawara Y; Yasuhara M; Okumura K; Kawakatsu K; Nishimura K; Hori R
    Biol Pharm Bull; 1993 May; 16(5):501-5. PubMed ID: 8364499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theophylline disposition in patients with hepatic cirrhosis.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    N Engl J Med; 1977 Jun; 296(26):1495-7. PubMed ID: 865528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of theophylline clearance in children with bronchial asthma.
    Yamazaki M; Fukutomi O; Kondo N; Orii T
    J Investig Allergol Clin Immunol; 1995; 5(1):50-3. PubMed ID: 7551206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of theophylline in hepatic disease.
    Mangione A; Imhoff TE; Lee RV; Shum LY; Jusko WJ
    Chest; 1978 May; 73(5):616-22. PubMed ID: 648214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the "condition correction factor" method of estimating theophylline clearance.
    Gotz VP; Russell WL; Lopez LM
    Ther Drug Monit; 1983; 5(1):103-7. PubMed ID: 6845393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.
    Bauer LA; Blouin RA
    Clin Pharmacokinet; 1981; 6(6):469-74. PubMed ID: 7318306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline disposition in adolescents with asthma.
    Cary J; Hein K; Dell R
    Ther Drug Monit; 1991 Jul; 13(4):309-13. PubMed ID: 1780962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of low-dose methotrexate in adult asthmatics.
    Glynn-Barnhart AM; Erzurum SC; Leff JA; Martin RJ; Cochran JE; Cott GR; Szefler SJ
    Pharmacotherapy; 1992; 12(5):383-90. PubMed ID: 1437699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.